FDA Inspection
GSK Vaccines GmbHGSK Vaccines GmbH – FDA Inspection, Nov 12, 2024
Record Details
This FDA Inspection record concerns GSK Vaccines GmbH, with an inspection on November 12, 2024, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · b827adbf-c9b5-468d-ab8f-c3d28097a1bb
Inspection Facts
- Inspection number
- 1255726
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of GSK Vaccines GmbH
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2026 | Not classified | Office of Inspections and Investigations | |
| March 6, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 25, 2018 | Not classified | Office of Inspections and Investigations | |
| May 25, 2016 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 30, 2014 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for GSK Vaccines GmbH
- FDA Inspection 1308794 - 2026-02-27
- FDA Inspection 1232008 - 2024-03-06
- FDA Inspection 1053492 - 2018-05-25
- FDA Inspection 1021717 - 2016-05-25
- FDA Inspection 888447 - 2014-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.